These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1555 related items for PubMed ID: 21329862

  • 1. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [Abstract] [Full Text] [Related]

  • 2. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 3. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 4. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 5. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP, Ward MR.
    Ann Emerg Med; 2000 Jul 20; 36(1):1-9. PubMed ID: 10874228
    [Abstract] [Full Text] [Related]

  • 6. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M.
    Europace; 2011 Mar 20; 13(3):329-45. PubMed ID: 21227948
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, Bruna C, Vincenti A, Verlato R, PAF 2 Study Investigators.
    Eur Heart J; 2002 Jun 20; 23(11):892-900. PubMed ID: 12042011
    [Abstract] [Full Text] [Related]

  • 8. Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.
    Chandramouli BV, Kotler MN.
    Geriatrics; 1998 Jun 20; 53(6):46-8, 51-2, 54, 57-60. PubMed ID: 9634106
    [Abstract] [Full Text] [Related]

  • 9. Atrial fibrillation and atrial flutter.
    Geraets DR, Kienzle MG.
    Clin Pharm; 1993 Oct 20; 12(10):721-35; quiz 783-4. PubMed ID: 7903069
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2340-7. PubMed ID: 17161267
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N, Papadopoulos N, Papanastasiou S, Kozirakis M, Maligkos G, Tsaritsaniotis E, Katsaris G.
    Pacing Clin Electrophysiol; 2005 Sep 05; 28(9):954-61. PubMed ID: 16176535
    [Abstract] [Full Text] [Related]

  • 12. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery.
    Mitchell LB, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Sep 05; 27(1):91-7. PubMed ID: 21329866
    [Abstract] [Full Text] [Related]

  • 13. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
    Bandini A, Golia P, Pantoli D, Galvani M, Rusticali F.
    Ital Heart J; 2005 Jul 05; 6(7):584-90. PubMed ID: 16274021
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D, Opolski G, Torbicki A.
    Med Sci Monit; 2001 Jul 05; 7(1):68-73. PubMed ID: 11208496
    [Abstract] [Full Text] [Related]

  • 15. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH, EURIDIS and ADONIS Investigators.
    N Engl J Med; 2007 Sep 06; 357(10):987-99. PubMed ID: 17804843
    [Abstract] [Full Text] [Related]

  • 16. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN.
    J Cardiovasc Pharmacol Ther; 2010 Dec 06; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [Abstract] [Full Text] [Related]

  • 17. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 18. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
    Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR.
    J Cardiovasc Electrophysiol; 2012 May 18; 23(5):462-72. PubMed ID: 22171925
    [Abstract] [Full Text] [Related]

  • 19. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    Humphries KH, Kerr CR, Steinbuch M, Dorian P, Canadian Registry of Atrial Fibrillation investigators.
    CMAJ; 2004 Sep 28; 171(7):741-5. PubMed ID: 15451836
    [Abstract] [Full Text] [Related]

  • 20. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 28; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.